SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-028132
Filing Date
2018-04-30
Accepted
2018-04-30 08:52:31
Documents
7
Period of Report
2018-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-12390_18k.htm 8-K 53883
2 EX-1.1 a18-12390_1ex1d1.htm EX-1.1 242015
3 EX-3.1 a18-12390_1ex3d1.htm EX-3.1 99109
4 EX-4.1 a18-12390_1ex4d1.htm EX-4.1 92842
5 EX-4.2 a18-12390_1ex4d2.htm EX-4.2 120938
6 EX-10.1 a18-12390_1ex10d1.htm EX-10.1 20980
7 EX-99.1 a18-12390_1ex99d1.htm EX-99.1 13077
  Complete submission text file 0001104659-18-028132.txt   644327
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 18786873
SIC: 2834 Pharmaceutical Preparations